Kemwell Biopharma

In the past few decades, biological therapeutics have performed a significant role in fighting against autoimmune disorders, cancers, and diseases that small molecule drugs have been unsuccessful in alleviating. The fast growth of therapeutic recombinant proteins is mainly because of technological advancement in cell line engineering, clone screening, and expression vector design. The primary goal in recombinant protein development is to produce a stable monoclonal cell line that consistently expresses the given recombinant protein at the desired quality through a cost-effective and efficient manufacturing process. Today  biosimilar development  has moved to a new phase guided by genomic insights and research, together with evolving technologies that are driving cell engineering into an uncharted future. People working in cell line development technology in the biopharma industry must cope with several contradictory priorities. They often must present their co-worker...

With the advancing technological world, the medical field is also developing at a fast pace. When a person is not from the medical field, then he/she can’t find the actual difference between biotech and biopharmaceutical companies . Both of the companies deal with medicines and drugs but there is a huge difference between both of them.  In biopharmaceutical companies, the best methods are used for the production and design of products but in biotech companies, whole research is done after which development takes place. Various tests are conducted before the manufacturing starts and then the work of selling drugs is done at the final stage. Know about biotechnology This technology is based on the subject biology and all the products which use living organisms are qualified in biotechnology. There are some people who think that it is a modern application which treats diseases and enhance the level of the environment while improves manufacturing processes also. There a...

For pharmaceutical companies, improved R&D productivity is a big challenge at the present time. There is always pressure to increase the development speed for the drugs and making it better as well as cost effective for the customers. The Pharmaceutical organisations are trying to hit the markets with the most promising and cost-effective drug products to provide the benefits to the maximum number of patients. However, there is always a big requirement of speeding up the development process by completing all the stages of the drug development process. As you know, there will be different stages during the process of drug development. It is very important to characterize the properties of drug substances in the early stages so that it can be easy to optimise the formulation of a drug product in the market. During the early stages of drug substance development , the companies understand the requirement of efficiency as well as safety. The formulation development can be ...